أعرض في EDS

Early treatment with high-potency statins in patients with acute coronary syndrome—an example of personalized medicine

التفاصيل البيبلوغرافية
العنوان: Early treatment with high-potency statins in patients with acute coronary syndrome—an example of personalized medicine
المؤلفون: Emanuel Harari, Alon Eisen
بيانات النشر: AME Publishing Company, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Acute coronary syndrome, medicine.medical_specialty, 030204 cardiovascular system & hematology, MIRACL, law.invention, Coronary artery disease, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Medicine, Potency, In patient, cardiovascular diseases, 030212 general & internal medicine, Aspirin, business.industry, medicine.disease, Editorial, Cardiology, lipids (amino acids, peptides, and proteins), Personalized medicine, business, medicine.drug
الوصف: Statins, together with aspirin, are the cornerstone of secondary prevention treatment in stable coronary artery disease (CAD) and acute coronary syndrome (ACS). The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study was one of the first randomized controlled trials which demonstrated a benefit of high-potency statin therapy in the setting of ACS (1).
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0643934c5bcef58eb9bdfa317525de
https://europepmc.org/articles/PMC6036014/
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....1e0643934c5bcef58eb9bdfa317525de
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.